Side-by-side comparison of AI visibility scores, market position, and capabilities
On-demand insurance pioneer (founded 2012) acquired by Travelers Insurance (NYSE: TRV) February 2022; raised $114M from Liberty Mutual/Sompo/Munich Re for micro-duration single-item mobile insurance before embedded insurance API exit.
Trōv was a San Francisco, California-based on-demand insurance technology company — having raised over $114 million from venture capital investors and strategic partners including Liberty Mutual, Sompo Holdings, Munich Re, and others — that pioneered micro-duration and embedded insurance before its technology assets were acquired by Travelers Insurance Group (NYSE: TRV) in February 2022. Founded in 2012 by CEO Scott Walchek (co-founder of Macromedia and early Baidu investor), Trōv launched in 2016 with the world's first mobile app for on-demand single-item insurance, enabling users to insure individual items (guitars, laptops, cameras) with micro-premiums measured in cents, turning coverage on and off with a swipe for protection lasting as little as seconds. The platform evolved from consumer on-demand insurance into an enterprise embedded insurance API that powered insurance distribution for gig economy platforms, transportation companies, and autonomous vehicle operators — before Travelers acquired its technology assets to enhance Travelers' Personal Insurance digital capabilities.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.